Lin, Y., Lin, X., Xia, R., Chen, J., Lin, Z., Lu, S. (2025). Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy. PLoS ONE. https://doi.org/10.1371/journal.pone.0327298